July 10, 2017 / 12:22 PM / 10 days ago

BRIEF-Cesca Therapeutics says acquires cell processing systems of SynGen

1 Min Read

July 10 (Reuters) - Cesca Therapeutics Inc

* Cesca therapeutics acquires the cell processing systems of syngen under asset acquisition agreement

* Cesca therapeutics inc - wholly-owned subsidiary, thermogenesis corp., has entered into an asset acquisition agreement with syngen inc

* Cesca therapeutics inc- ‍wholly-owned subsidiary, thermogenesis corp., has entered into an asset acquisition agreement with syngen inc​

* Cesca therapeutics inc- ‍representative of syngen's majority shareholder, bay city capital, has joined board of directors of themogenesis​

* Cesca therapeutics - philip coelho, co-founder and cto of syngen, has joined thermogenesis in chief technology officer role, effective immediately

* Cesca therapeutics inc- ‍in exchange for assets, thermogenesis granted syngen 20% of its common stock and paid a one-time cash payment of $1 million​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below